TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs7159300
log Bayes Factor = 0.0388465
Chromosome 14   position 72,883,874  (GRCh37) Explore rs7159300 on Ensembl!
Variant rs7159300 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
D69 Purpura and other haemorrhagic conditions
0.000 0.900 0.100
D69.3 Idiopathic thrombocytopenic purpura
0.000 0.904 0.096
D69.6 Thrombocytopenia, unspecified
0.000 0.905 0.095
D69.9 Haemorrhagic condition, unspecified
0.000 0.909 0.091
D65-D69 Coagulation defects, purpura and other haemorrhagic conditions
0.000 0.909 0.091
D68 Other coagulation defects
0.000 0.909 0.091
D68.3 Haemorrhagic disorder due to circulating anticoagulants
0.000 0.916 0.084
D69.4 Other primary thrombocytopenia
0.000 0.918 0.082
D68.8 Other specified coagulation defects
0.000 0.920 0.080
D68.5 Primary Thrombophilia
0.000 0.922 0.078
D68.9 Coagulation defect, unspecified
0.000 0.924 0.076
D69.2 Other nonthrombocytopenic purpura
0.000 0.925 0.075
D69.8 Other specified haemorrhagic conditions
0.000 0.928 0.072
D69.1 Qualitative platelet defects
0.000 0.928 0.072
D65 Disseminated intravascular coagulation [defibrination syndrome]
0.000 0.929 0.071
D72.8 Other specified disorders of white blood cells
0.000 0.929 0.071
D68.0 Von Willebrand's disease
0.000 0.929 0.071
D68.4 Acquired coagulation factor deficiency
0.000 0.933 0.067
D67 Hereditary factor IX deficiency
0.000 0.934 0.065
D69.5 Secondary thrombocytopenia
0.000 0.935 0.065
D68.2 Hereditary deficiency of other clotting factors
0.000 0.938 0.062
D69.0 Allergic purpura
0.000 0.940 0.059
D68.6 Other Thrombophilia
0.000 0.942 0.058
I44.2 Atrioventricular block, complete
0.000 0.945 0.055
D68.1 Hereditary factor XI deficiency
0.000 0.947 0.052
D72 Other disorders of white blood cells
0.000 0.950 0.050
D66 Hereditary factor VIII deficiency
0.000 0.955 0.045
I44 Atrioventricular and left bundle-branch block
0.000 0.960 0.040
I44.1 Atrioventricular block, second degree
0.000 0.962 0.038
R19.8 Other specified symptoms and signs involving the digestive system and abdomen
0.000 0.963 0.037
D72.9 Disorder of white blood cells, unspecified
0.000 0.964 0.036
D72.0 Genetic anomalies of leukocytes
0.000 0.964 0.036
D72.1 Eosinophilia
0.000 0.964 0.036
D70-D77 Other diseases of blood and blood-forming organs
0.000 0.965 0.035
Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
0.000 0.965 0.035
I44.3 Other and unspecified atrioventricular block
0.000 0.967 0.033
D76 Certain diseases involving lymphoreticular tissue and reticulohistiocytic system
0.000 0.969 0.031
I44.0 Atrioventricular block, first degree
0.000 0.970 0.030
I44.5 Left posterior fascicular block
0.000 0.971 0.029
I44.4 Left anterior fascicular block
0.000 0.971 0.029
D76.3 Other histiocytosis syndromes
0.000 0.973 0.027
I44.6 Other and unspecified fascicular block
0.000 0.973 0.027
D74 Methaemoglobinaemia
0.000 0.974 0.026
D77 Other disorders of blood and blood-forming organs in diseases classified elsewhere
0.000 0.974 0.026
D71 Functional disorders of polymorphonuclear neutrophils
0.000 0.974 0.026
D76.2 Haemophagocytic syndrome, infection-associated
0.000 0.978 0.022
D76.1 Haemophagocytic lymphohistiocytosis
0.000 0.978 0.022
D76.0 Langerhans' cell histiocytosis, not elsewhere classified
0.000 0.978 0.022
I44.7 Left bundle-branch block, unspecified
0.000 0.978 0.022
D80-D89 Certain disorders involving the immune mechanism
0.000 0.978 0.022
D55-D59 Haemolytic anaemias
0.000 0.979 0.021
D74.9 Methaemoglobinaemia, unspecified
0.000 0.981 0.018
D74.8 Other methaemoglobinaemias
0.000 0.981 0.018
D74.0 Congenital methaemoglobinaemia
0.000 0.981 0.018
D80 Immunodeficiency with predominantly antibody defects
0.000 0.982 0.018
D83 Common variable immunodeficiency
0.000 0.983 0.017
D84 Other immunodeficiencies
0.000 0.984 0.016
D81 Combined immunodeficiencies
0.000 0.984 0.016
D73 Diseases of spleen
0.000 0.985 0.015
D57 Sickle-cell disorders
0.000 0.985 0.015
D55 Anaemia due to enzyme disorders
0.000 0.985 0.015
D82 Immunodeficiency associated with other major defects
0.000 0.985 0.015
D56 Thalassaemia
0.000 0.985 0.015
D80.2 Selective deficiency of immunoglobulin A [IgA]
0.000 0.985 0.015
D83.9 Common variable immunodeficiency, unspecified
0.000 0.986 0.014
D60-D64 Aplastic and other anaemias
0.000 0.986 0.014
D75 Other diseases of blood and blood-forming organs
0.000 0.986 0.014
D59 Acquired haemolytic anaemia
0.000 0.986 0.014
D58 Other hereditary haemolytic anaemias
0.000 0.986 0.014
D80.3 Selective deficiency of immunoglobulin G [IgG] subclasses
0.000 0.986 0.013
D89 Other disorders involving the immune mechanism, not elsewhere classified
0.000 0.987 0.013
D80.1 Nonfamilial hypogammaglobulinaemia
0.000 0.987 0.013
D80.9 Immunodeficiency with predominantly antibody defects, unspecified
0.000 0.987 0.013
D80.8 Other immunodeficiencies with predominantly antibody defects
0.000 0.987 0.013
D80.7 Transient hypogammaglobulinaemia of infancy
0.000 0.987 0.013
D80.6 Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia
0.000 0.987 0.013
D80.5 Immunodeficiency with increased immunoglobulin M [IgM]
0.000 0.987 0.013
D80.4 Selective deficiency of immunoglobulin M [IgM]
0.000 0.987 0.013
D80.0 Hereditary hypogammaglobulinaemia
0.000 0.987 0.013
D83.8 Other common variable immunodeficiencies
0.000 0.987 0.013
D83.2 Common variable immunodeficiency with autoantibodies to B- or T-cells
0.000 0.987 0.013
D83.1 Common variable immunodeficiency with predominant immunoregulatory T-cell disorders
0.000 0.987 0.013
D83.0 Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function
0.000 0.987 0.013
A49.8 Other bacterial infections of unspecified site
0.000 0.987 0.013
D62 Acute posthaemorrhagic anaemia
0.000 0.987 0.013
D73.8 Other diseases of spleen
0.000 0.988 0.012
D84.9 Immunodeficiency, unspecified
0.000 0.988 0.012
T50.9 Other and unspecified drugs, medicaments and biological substances
0.012 0.988 0.000
D84.8 Other specified immunodeficiencies
0.000 0.988 0.012
D84.1 Defects in the complement system
0.000 0.988 0.012
D84.0 Lymphocyte function antigen-1 [LFA-1] defect
0.000 0.988 0.012
D81.9 Combined immunodeficiency, unspecified
0.000 0.988 0.011
D81.8 Other combined immunodeficiencies
0.000 0.988 0.011
D81.7 Major histocompatibility complex class II deficiency
0.000 0.988 0.011
D81.6 Major histocompatibility complex class I deficiency
0.000 0.988 0.011
D81.5 Purine nucleoside phosphorylase [PNP] deficiency
0.000 0.988 0.011
D81.4 Nezelof's syndrome
0.000 0.988 0.011
D81.3 Adenosine deaminase [ADA] deficiency
0.000 0.988 0.011
D81.2 Severe combined immunodeficiency [SCID] with low or normal B-cell numbers
0.000 0.988 0.011
D81.1 Severe combined immunodeficiency [SCID] with low T- and B-cell numbers
0.000 0.988 0.011
D81.0 Severe combined immunodeficiency [SCID] with reticular dysgenesis
0.000 0.988 0.011
D73.9 Disease of spleen, unspecified
0.000 0.989 0.011
D73.3 Abscess of spleen
0.000 0.989 0.011
D73.2 Chronic congestive splenomegaly
0.000 0.989 0.011
D55.9 Anaemia due to enzyme disorder, unspecified
0.000 0.989 0.011
D55.8 Other anaemias due to enzyme disorders
0.000 0.989 0.011
D55.3 Anaemia due to disorders of nucleotide metabolism
0.000 0.989 0.011
D55.2 Anaemia due to disorders of glycolytic enzymes
0.000 0.989 0.011
D55.1 Anaemia due to other disorders of glutathione metabolism
0.000 0.989 0.011
D55.0 Anaemia due to glucose-6-phosphate dehydrogenase [G6PD] deficiency
0.000 0.989 0.011
D57.8 Other sickle-cell disorders
0.000 0.989 0.011
D57.3 Sickle-cell trait
0.000 0.989 0.011
D57.2 Double heterozygous sickling disorders
0.000 0.989 0.011
D57.1 Sickle-cell anaemia without crisis
0.000 0.989 0.011
D57.0 Sickle-cell anaemia with crisis
0.000 0.989 0.011
D75.9 Disease of blood and blood-forming organs, unspecified
0.000 0.989 0.011
D82.9 Immunodeficiency associated with major defect, unspecified
0.000 0.989 0.011
D82.8 Immunodeficiency associated with other specified major defects
0.000 0.989 0.011
D82.4 Hyperimmunoglobulin E [IgE] syndrome
0.000 0.989 0.011
D82.3 Immunodeficiency following hereditary defective response to Epstein-Barr virus
0.000 0.989 0.011
D82.2 Immunodeficiency with short-limbed stature
0.000 0.989 0.011
D82.0 Wiskott-Aldrich syndrome
0.000 0.989 0.011
D56.9 Thalassaemia, unspecified
0.000 0.989 0.011
D56.8 Other thalassaemias
0.000 0.989 0.011
D56.4 Hereditary persistence of foetal haemoglobin [HPFH]
0.000 0.989 0.011
D56.2 Delta-beta thalassaemia
0.000 0.989 0.011
D56.0 Alpha thalassaemia
0.000 0.989 0.011
D56.1 Beta thalassaemia
0.000 0.989 0.011
D73.1 Hypersplenism
0.000 0.989 0.010
D50-D53 Nutritional anaemias
0.000 0.989 0.010
D73.5 Infarction of spleen
0.000 0.990 0.010
D60 Acquired pure red cell aplasia [erythroblastopenia]
0.000 0.990 0.010
D59.1 Other autoimmune haemolytic anaemias
0.000 0.990 0.010
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.010 0.990 0.000
D82.1 Di George's syndrome
0.000 0.990 0.010
D56.3 Thalassaemia trait
0.000 0.990 0.010
D89.9 Disorder involving the immune mechanism, unspecified
0.000 0.990 0.010
D59.8 Other acquired haemolytic anaemias
0.000 0.990 0.010
D59.6 Haemoglobinuria due to haemolysis from other external causes
0.000 0.990 0.010
D59.5 Paroxysmal nocturnal haemoglobinuria [Marchiafava-Micheli]
0.000 0.990 0.010
D59.4 Other nonautoimmune haemolytic anaemias
0.000 0.990 0.010
D59.3 Haemolytic-uraemic syndrome
0.000 0.990 0.010
D59.2 Drug-induced nonautoimmune haemolytic anaemia
0.000 0.990 0.010
D59.0 Drug-induced autoimmune haemolytic anaemia
0.000 0.990 0.010
D58.9 Hereditary haemolytic anaemia, unspecified
0.000 0.990 0.010
D58.8 Other specified hereditary haemolytic anaemias
0.000 0.990 0.010
D58.1 Hereditary elliptocytosis
0.000 0.990 0.010
D89.2 Hypergammaglobulinaemia, unspecified
0.000 0.990 0.010
D86 Sarcoidosis
0.000 0.990 0.010
D89.3 Immune reconstitution syndrome
0.000 0.990 0.010
D73.4 Cyst of spleen
0.000 0.990 0.009
Z46.6 Fitting and adjustment of urinary device
0.009 0.991 0.000
D58.0 Hereditary spherocytosis
0.000 0.991 0.009
N31.9 Neuromuscular dysfunction of bladder, unspecified
0.009 0.991 0.000
D58.2 Other haemoglobinopathies
0.000 0.991 0.009
D89.0 Polyclonal hypergammaglobulinaemia
0.000 0.991 0.009
D75.0 Familial erythrocytosis
0.000 0.991 0.009
V18.0 Driver injured in nontraffic accident
0.009 0.991 0.000
D89.8 Other specified disorders involving the immune mechanism, not elsewhere classified
0.000 0.991 0.009
D75.8 Other specified diseases of blood and blood-forming organs
0.000 0.991 0.009
D75.2 Essential thrombocytosis
0.000 0.991 0.009
N31.2 Flaccid neuropathic bladder, not elsewhere classified
0.009 0.991 0.000
T36-T50 Poisoning by drugs, medicaments and biological substances
0.008 0.992 0.000
D52 Folate deficiency anaemia
0.000 0.992 0.008
D59.9 Acquired haemolytic anaemia, unspecified
0.000 0.992 0.008
T50.8 Diagnostic agents
0.008 0.992 0.000
D86.8 Sarcoidosis of other and combined sites
0.000 0.992 0.008
N31 Neuromuscular dysfunction of bladder, not elsewhere classified
0.008 0.992 0.000
D89.1 Cryoglobulinaemia
0.000 0.992 0.008
D86.1 Sarcoidosis of lymph nodes
0.000 0.992 0.008
T50.6 Antidotes and chelating agents, not elsewhere classified
0.008 0.992 0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.008 0.992 0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.008 0.992 0.000
D60.9 Acquired pure red cell aplasia, unspecified
0.000 0.992 0.007
D60.8 Other acquired pure red cell aplasias
0.000 0.992 0.007
D60.1 Transient acquired pure red cell aplasia
0.000 0.992 0.007
D60.0 Chronic acquired pure red cell aplasia
0.000 0.992 0.007
T50.7 Analeptics and opioid receptor antagonists
0.008 0.992 0.000
T50.5 Appetite depressants
0.008 0.992 0.000
T50.3 Electrolytic, caloric and water-balance agents
0.008 0.992 0.000
T50.1 Loop [high-ceiling] diuretics
0.008 0.992 0.000
T50.0 Mineralocorticoids and their antagonists
0.008 0.992 0.000
T50.4 Drugs affecting uric acid metabolism
0.008 0.992 0.000
D61 Other aplastic anaemias
0.000 0.992 0.008
L28.0 Lichen simplex chronicus
0.008 0.992 0.000
T46 Poisoning by agents primarily affecting the cardiovascular system
0.007 0.993 0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.007 0.993 0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.007 0.993 0.000
D86.3 Sarcoidosis of skin
0.000 0.993 0.007
F43.2 Adjustment disorders
0.000 0.993 0.007
T36 Poisoning by systemic antibiotics
0.007 0.993 0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.007 0.993 0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.007 0.993 0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.007 0.993 0.000
N31.8 Other neuromuscular dysfunction of bladder
0.007 0.993 0.000
D53 Other nutritional anaemias
0.000 0.993 0.007
F45.8 Other somatoform disorders
0.000 0.993 0.007
D86.2 Sarcoidosis of lung with sarcoidosis of lymph nodes
0.000 0.993 0.006
D52.9 Folate deficiency anaemia, unspecified
0.000 0.993 0.007
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.006 0.993 0.000
T47.1 Other antacids and anti-gastric-secretion drugs
0.006 0.993 0.000
T38.1 Thyroid hormones and substitutes
0.006 0.994 0.000
T45.5 Anticoagulants
0.006 0.994 0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.006 0.994 0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.006 0.994 0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.006 0.994 0.000
T46.4 Angiotensin-converting-enzyme inhibitors
0.006 0.994 0.000
T36.0 Penicillins
0.006 0.994 0.000
T41 Poisoning by anaesthetics and therapeutic gases
0.006 0.994 0.000
D52.8 Other folate deficiency anaemias
0.000 0.994 0.006
D52.1 Drug-induced folate deficiency anaemia
0.000 0.994 0.006
D52.0 Dietary folate deficiency anaemia
0.000 0.994 0.006
N31.0 Uninhibited neuropathic bladder, not elsewhere classified
0.006 0.994 0.000
V18 Pedal cyclist injured in noncollision transport accident
0.006 0.994 0.000
T46.1 Calcium-channel blockers
0.006 0.994 0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.006 0.994 0.000
T47.6 Antidiarrhoeal drugs
0.006 0.994 0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.006 0.994 0.000
I70.20 Atherosclerosis of arteries of extremities (without gangrene)
0.006 0.994 0.000
N31.1 Reflex neuropathic bladder, not elsewhere classified
0.006 0.994 0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.006 0.994 0.000
T38.9 Other and unspecified hormone antagonists
0.006 0.994 0.000
T38.8 Other and unspecified hormones and their synthetic substitutes
0.006 0.994 0.000
T38.7 Androgens and anabolic congeners
0.006 0.994 0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.006 0.994 0.000
T38.5 Other oestrogens and progestogens
0.006 0.994 0.000
T38.4 Oral contraceptives
0.006 0.994 0.000
T38.2 Antithyroid drugs
0.006 0.994 0.000
T38.0 Glucocorticoids and synthetic analogues
0.006 0.994 0.000
D64 Other anaemias
0.000 0.994 0.006
N45.9 Orchitis, epididymitis and epididymo-orchitis without abscess
0.006 0.994 0.000
D61.8 Other specified aplastic anaemias
0.000 0.994 0.006
D61.3 Idiopathic aplastic anaemia
0.000 0.994 0.006
D61.2 Aplastic anaemia due to other external agents
0.000 0.994 0.006
D61.1 Drug-induced aplastic anaemia
0.000 0.994 0.006
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.005 0.994 0.000
T46.8 Antivaricose drugs, including sclerosing agents
0.005 0.994 0.000
T46.7 Peripheral vasodilators
0.005 0.994 0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.005 0.994 0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.005 0.994 0.000
Z90.2 Acquired absence of lung [part of]
0.000 0.994 0.006
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.005 0.994 0.000
T47.8 Other agents primarily affecting the gastro-intestinal system
0.005 0.994 0.000
T47.7 Emetics
0.005 0.994 0.000
T47.5 Digestants
0.005 0.994 0.000
T47.4 Other laxatives
0.005 0.994 0.000
T47.3 Saline and osmotic laxatives
0.005 0.994 0.000
T47.2 Stimulant laxatives
0.005 0.994 0.000
T47.0 Histamine H(2)-receptor antagonists
0.005 0.994 0.000
S61.9 Open wound of wrist and hand, part unspecified
0.006 0.994 0.000
D73.0 Hyposplenism
0.000 0.994 0.005
D70 Agranulocytosis
0.000 0.994 0.006
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.006 0.994 0.000
A49 Bacterial infection of unspecified site
0.000 0.994 0.006
D51 Vitamin B12 deficiency anaemia
0.000 0.995 0.005
T45.1 Antineoplastic and immunosuppressive drugs
0.005 0.995 0.000
T36.9 Systemic antibiotic, unspecified
0.005 0.995 0.000
T36.8 Other systemic antibiotics
0.005 0.995 0.000
T36.7 Antifungal antibiotics, systemically used
0.005 0.995 0.000
T36.6 Rifamycins
0.005 0.995 0.000
T36.5 Aminoglycosides
0.005 0.995 0.000
T36.4 Tetracyclines
0.005 0.995 0.000
T36.3 Macrolides
0.005 0.995 0.000
T36.2 Chloramphenicol group
0.005 0.995 0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.005 0.995 0.000
T45.9 Primarily systemic and haematological agent, unspecified
0.005 0.995 0.000
T45.8 Other primarily systemic and haematological agents
0.005 0.995 0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.005 0.995 0.000
T45.6 Fibrinolysis-affecting drugs
0.005 0.995 0.000
T45.4 Iron and its compounds
0.005 0.995 0.000
T45.3 Enzymes, not elsewhere classified
0.005 0.995 0.000
T49.9 Topical agent, unspecified
0.005 0.995 0.000
T49.8 Other topical agents
0.005 0.995 0.000
T49.7 Dental drugs, topically applied
0.005 0.995 0.000
T49.6 Otorhinolaryngological drugs and preparations
0.005 0.995 0.000
T49.5 Ophthalmological drugs and preparations
0.005 0.995 0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.005 0.995 0.000
T49.3 Emollients, demulcents and protectants
0.005 0.995 0.000
T49.2 Local astringents and local detergents
0.005 0.995 0.000
T49.1 Antipruritics
0.005 0.995 0.000
T46.3 Coronary vasodilators, not elsewhere classified
0.005 0.995 0.000
T40.3 Methadone
0.005 0.995 0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.005 0.995 0.000
D53.8 Other specified nutritional anaemias
0.000 0.995 0.005
D53.2 Scorbutic anaemia
0.000 0.995 0.005
D53.1 Other megaloblastic anaemias, not elsewhere classified
0.000 0.995 0.005
D53.0 Protein deficiency anaemia
0.000 0.995 0.005
D63 Anaemia in chronic diseases classified elsewhere
0.000 0.995 0.005
T46.5 Other antihypertensive drugs, not elsewhere classified
0.005 0.995 0.000
F45 Somatoform disorders
0.000 0.995 0.005
D61.0 Constitutional aplastic anaemia
0.000 0.995 0.005
T45.2 Vitamins, not elsewhere classified
0.005 0.995 0.000
V10-V19 Pedal cyclist injured in transport accident
0.005 0.995 0.000
K04.5 Chronic apical periodontitis
0.005 0.995 0.000
T40.5 Cocaine
0.005 0.995 0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.005 0.995 0.000
T40.6 Other and unspecified narcotics
0.005 0.995 0.000
T48.6 Antiasthmatics, not elsewhere classified
0.005 0.995 0.000
T39.4 Antirheumatics, not elsewhere classified
0.005 0.995 0.000
T39.2 Pyrazolone derivatives
0.005 0.995 0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.005 0.995 0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.005 0.995 0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.005 0.995 0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.005 0.995 0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.005 0.995 0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.005 0.995 0.000
T44.1 Other parasympathomimetics [cholinergics]
0.005 0.995 0.000
T44.0 Anticholinesterase agents
0.005 0.995 0.000
T45.0 Antiallergic and antiemetic drugs
0.005 0.995 0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.005 0.995 0.000
T48.5 Anti-common-cold drugs
0.005 0.995 0.000
T48.4 Expectorants
0.005 0.995 0.000
T48.3 Antitussives
0.005 0.995 0.000
T48.2 Other and unspecified agents primarily acting on muscles
0.005 0.995 0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.005 0.995 0.000
T48.0 Oxytocic drugs
0.005 0.995 0.000
F40.2 Specific (isolated) phobias
0.000 0.995 0.005
V18.3 Person injured while boarding or alighting
0.005 0.995 0.000
T41.5 Therapeutic gases
0.005 0.995 0.000
T41.4 Anaesthetic, unspecified
0.005 0.995 0.000
T41.3 Local anaesthetics
0.005 0.995 0.000
T41.2 Other and unspecified general anaesthetics
0.005 0.995 0.000
T41.1 Intravenous anaesthetics
0.005 0.995 0.000
T41.0 Inhaled anaesthetics
0.005 0.995 0.000
D75.1 Secondary polycythaemia
0.000 0.995 0.005
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.005 0.995 0.000
V18.9 Unspecified pedal cyclist injured in traffic accident
0.005 0.995 0.000
V18.4 Driver injured in traffic accident
0.005 0.995 0.000
V18.5 Passenger injured in traffic accident
0.005 0.995 0.000
V18.1 Passenger injured in nontraffic accident
0.005 0.995 0.000
D86.0 Sarcoidosis of lung
0.000 0.995 0.004
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.005 0.995 0.000
Z50.8 Care involving use of rehabilitation procedures
0.005 0.995 0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.004 0.995 0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.004 0.995 0.000
T37.5 Antiviral drugs
0.004 0.995 0.000
T37.4 Anthelminthics
0.004 0.995 0.000
T37.3 Other antiprotozoal drugs
0.004 0.995 0.000
T37.2 Antimalarials and drugs acting on other blood protozoa
0.004 0.995 0.000
T37.1 Antimycobacterial drugs
0.004 0.995 0.000
T37.0 Sulphonamides
0.004 0.995 0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.004 0.995 0.000
V19 Pedal cyclist injured in other and unspecified transport accidents
0.004 0.995 0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.004 0.996 0.000
T40.8 Lysergide [LSD]
0.004 0.996 0.000
T40.7 Cannabis (derivatives)
0.004 0.996 0.000
T40.1 Heroin
0.004 0.996 0.000
T40.0 Opium
0.004 0.996 0.000
F43 Reaction to severe stress, and adjustment disorders
0.000 0.996 0.004
M25.96 Joint disorder, unspecified (Lower leg)
0.004 0.996 0.000
D64.4 Congenital dyserythropoietic anaemia
0.000 0.996 0.004
D64.3 Other sideroblastic anaemias
0.000 0.996 0.004
D64.2 Secondary sideroblastic anaemia due to drugs and toxins
0.000 0.996 0.004
D64.1 Secondary sideroblastic anaemia due to disease
0.000 0.996 0.004
D64.0 Hereditary sideroblastic anaemia
0.000 0.996 0.004
E10.5 With peripheral circulatory complications
0.000 0.996 0.004
C43.3 Malignant melanoma of other and unspecified parts of face
0.000 0.996 0.004
F45.0 Somatisation disorder
0.000 0.996 0.004
D64.8 Other specified anaemias
0.000 0.996 0.004
X59.2 School, other institution and public administrative area
0.004 0.996 0.000
D51.9 Vitamin B12 deficiency anaemia, unspecified
0.000 0.996 0.004
W51.9 Unspecified place
0.004 0.996 0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.004 0.996 0.000
A49.2 Haemophilus influenzae infection, unspecified
0.000 0.996 0.004
T42.5 Mixed antiepileptics, not elsewhere classified
0.004 0.996 0.000
T42.3 Barbiturates
0.004 0.996 0.000
T42.2 Succinimides and oxazolidinediones
0.004 0.996 0.000
T42.0 Hydantoin derivatives
0.004 0.996 0.000
A49.3 Mycoplasma infection, unspecified
0.000 0.996 0.004
D53.9 Nutritional anaemia, unspecified
0.000 0.996 0.004
D51.8 Other vitamin B12 deficiency anaemias
0.000 0.996 0.004
D51.3 Other dietary vitamin B12 deficiency anaemia
0.000 0.996 0.004
D51.2 Transcobalamin II deficiency
0.000 0.996 0.004
D51.1 Vitamin B12 deficiency anaemia due to selective vitamin B12 malabsorption with proteinuria
0.000 0.996 0.004
T37.8 Other specified systemic anti-infectives and antiparasitics
0.004 0.996 0.000
Z83.7 Family history of diseases of the digestive system
0.004 0.996 0.000
E21.3 Hyperparathyroidism, unspecified
0.000 0.996 0.004
W51 Striking against or bumped into by another person
0.004 0.996 0.000
A49.0 Staphylococcal infection, unspecified
0.000 0.996 0.004
D61.9 Aplastic anaemia, unspecified
0.000 0.996 0.004
V19.3 Pedal cyclist [any] injured in an unspecified nontraffic accident
0.004 0.996 0.000
A49.1 Streptococcal infection, unspecified
0.000 0.996 0.004
X47.0 Home
0.004 0.996 0.000
W50-W64 Exposure to animate mechanical forces
0.004 0.996 0.000
I70.2 Atherosclerosis of arteries of the extremities
0.004 0.996 0.000
V14 Pedal cyclist injured in collision with heavy transport vehicle or bus
0.004 0.996 0.000
X47 Accidental poisoning by and exposure to other gases and vapours
0.004 0.996 0.000
D63.1 Anaemia in other chronic diseases classified elsewhere
0.000 0.996 0.004
F43.0 Acute stress reaction
0.000 0.996 0.004
X59 Exposure to unspecified factor
0.004 0.996 0.000
F45.4 Persistent somatoform pain disorder
0.000 0.996 0.004
F45.2 Hypochondriacal disorder
0.000 0.996 0.004
F45.1 Undifferentiated somatoform disorder
0.000 0.996 0.004
W29 Contact with other powered hand tools and household machinery
0.004 0.996 0.000
X40-X49 Accidental poisoning by and exposure to noxious substances
0.004 0.996 0.000
W29.9 Unspecified place
0.004 0.996 0.000
F40 Phobic anxiety disorders
0.000 0.996 0.004
V10 Pedal cyclist injured in collision with pedestrian or animal
0.004 0.996 0.000
T39.0 Salicylates
0.004 0.996 0.000
X58-X59 Accidental exposure to other and unspecified factors
0.004 0.996 0.000
V16 Pedal cyclist injured in collision with other nonmotor vehicle
0.004 0.996 0.000
V15 Pedal cyclist injured in collision with railway train or railway vehicle
0.004 0.996 0.000
V13 Pedal cyclist injured in collision with car, pick-up truck or van
0.004 0.996 0.000
V12 Pedal cyclist injured in collision with two- or three-wheeled motor vehicle
0.004 0.996 0.000
W20-W49 Exposure to inanimate mechanical forces
0.004 0.996 0.000
I70.21 Atherosclerosis of arteries of extremities (with gangrene)
0.004 0.996 0.000
F40-F48 Neurotic, stress-related and somatoform disorders
0.000 0.996 0.004
Chapter XX External causes of morbidity and mortality
0.004 0.996 0.000
W23 Caught, crushed, jammed or pinched in or between objects
0.004 0.996 0.000
V17 Pedal cyclist injured in collision with fixed or stationary object
0.004 0.996 0.000
J93.9 Pneumothorax, unspecified
0.000 0.996 0.004
W23.2 School, other institution and public administrative area
0.004 0.996 0.000
Z83.3 Family history of diabetes mellitus
0.004 0.996 0.000
V20-V29 Motorcycle rider injured in transport accident
0.004 0.996 0.000
V23.4 Driver injured in traffic accident
0.004 0.996 0.000
F45.9 Somatoform disorder, unspecified
0.000 0.996 0.004
F45.3 Somatoform autonomic dysfunction
0.000 0.996 0.004
I20.8 Other forms of angina pectoris
0.000 0.996 0.004
Z86.3 Personal history of endocrine, nutritional and metabolic diseases
0.000 0.996 0.004
V23 Motorcycle rider injured in collision with car, pick-up truck or van
0.004 0.996 0.000
W57 Bitten or stung by non-venomous insect and other non-venomous arthropods
0.004 0.996 0.000
V18.49 Pedal cyclist injured in noncollision transport accident; driver injured in traffic accident ; during unspecified activity
0.003 0.996 0.000
V18.99 Pedal cyclist injured in noncollision transport accident; unspecified pedal cyclist injured in traffic accident; during unspecified activity
0.003 0.996 0.000
K07.6 Temporomandibular joint disorders
0.000 0.996 0.004
V19.8 Pedal cyclist [any] injured in other specified transport accidents
0.003 0.996 0.000
Y60-Y69 Misadventures to patients during surgical and medical care
0.004 0.996 0.000
X00-X09 Exposure to smoke, fire and flames
0.004 0.996 0.000
S61.1 Open wound of finger(s) with damage to nail
0.004 0.996 0.000
X42 Accidental poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified
0.003 0.996 0.000
X10-X19 Contact with heat and hot substances
0.003 0.996 0.000
V19.9 Pedal cyclist [any] injured in unspecified traffic accident
0.003 0.996 0.000
V19.6 Unspecified pedal cyclist injured in collision with other and unspecified motor vehicles in traffic accident
0.003 0.996 0.000
V19.2 Unspecified pedal cyclist injured in collision with other and unspecified motor vehicles in nontraffic accident
0.003 0.996 0.000
V19.5 Passenger injured in collision with other and unspecified motor vehicles in traffic accident
0.003 0.996 0.000
V19.4 Driver injured in collision with other and unspecified motor vehicles in traffic accident
0.003 0.996 0.000
V19.1 Passenger injured in collision with other and unspecified motor vehicles in nontraffic accident
0.003 0.996 0.000
V19.0 Driver injured in collision with other and unspecified motor vehicles in nontraffic accident
0.003 0.996 0.000
F43.8 Other reactions to severe stress
0.000 0.996 0.003
F44 Dissociative [conversion] disorders
0.000 0.996 0.003
L28 Lichen simplex chronicus and prurigo
0.003 0.997 0.000
T40.4 Other synthetic narcotics
0.003 0.997 0.000
Y60 Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care
0.003 0.997 0.000
W55 Bitten or struck by other mammals
0.003 0.997 0.000
W22.5 Trade and service area
0.003 0.997 0.000
M24.86 Other specific joint derangements, not elsewhere classified (Lower leg)
0.003 0.997 0.000
V11 Pedal cyclist injured in collision with other pedal cycle
0.003 0.997 0.000
X44 Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
0.003 0.997 0.000
W57.0 Home
0.003 0.997 0.000
W24 Contact with lifting and transmission devices, not elsewhere classified
0.003 0.997 0.000
Z83 Family history of other specific disorders
0.003 0.997 0.000
X47.9 Unspecified place
0.003 0.997 0.000
Y60.8 During other surgical and medical care
0.003 0.997 0.000
V40-V49 Car occupant injured in transport accident
0.003 0.997 0.000
W29.5 Trade and service area
0.003 0.997 0.000
X10 Contact with hot drinks, food, fats and cooking oils
0.003 0.997 0.000
V14.4 Driver injured in traffic accident
0.003 0.997 0.000
X42.2 School, other institution and public administrative area
0.003 0.997 0.000
T42.1 Iminostilbenes
0.003 0.997 0.000
V28 Motorcycle rider injured in noncollision transport accident
0.003 0.997 0.000
W34 Discharge from other and unspecified firearms
0.003 0.997 0.000
W51.8 Other specified place
0.003 0.997 0.000
W51.3 Sports and athletics area
0.003 0.997 0.000
W51.0 Home
0.003 0.997 0.000
W51.7 Farm
0.003 0.997 0.000
W51.6 Industrial and construction area
0.003 0.997 0.000
W51.5 Trade and service area
0.003 0.997 0.000
W51.4 Street and highway
0.003 0.997 0.000
W51.2 School, other institution and public administrative area
0.003 0.997 0.000
W51.1 Residential institution
0.003 0.997 0.000
X10.0 Home
0.003 0.997 0.000
W40 Explosion of other materials
0.003 0.997 0.000
W50 Hit, struck, kicked, twisted, bitten or scratched by another person
0.003 0.997 0.000
W59 Bitten or crushed by other reptiles
0.003 0.997 0.000
W58 Bitten or struck by crocodile or alligator
0.003 0.997 0.000
W56 Contact with marine animal
0.003 0.997 0.000
W54 Bitten or struck by dog
0.003 0.997 0.000
W53 Bitten by rat
0.003 0.997 0.000
W52 Crushed, pushed and stepped on by crowd or human stampede
0.003 0.997 0.000
X41 Accidental poisoning by and exposure to antiepileptic, sedative-hypnotic, anti-Parkinsonism and psychotropic drugs, not elsewhere classified
0.003 0.997 0.000
W20 Struck by thrown, projected or falling object
0.003 0.997 0.000
X58 Exposure to other specified factors
0.003 0.997 0.000
X08 Exposure to other specified smoke, fire and flames
0.003 0.997 0.000
M25.9 Joint disorder, unspecified
0.003 0.997 0.000
V14.9 Unspecified pedal cyclist injured in traffic accident
0.003 0.997 0.000
V14.5 Passenger injured in traffic accident
0.003 0.997 0.000
V14.3 Person injured while boarding or alighting
0.003 0.997 0.000
V14.2 Unspecified pedal cyclist injured in nontraffic accident
0.003 0.997 0.000
V14.1 Passenger injured in nontraffic accident
0.003 0.997 0.000
V14.0 Driver injured in nontraffic accident
0.003 0.997 0.000
X47.8 Other specified place
0.003 0.997 0.000
X47.7 Farm
0.003 0.997 0.000
X47.6 Industrial and construction area
0.003 0.997 0.000
X47.5 Trade and service area
0.003 0.997 0.000
X47.4 Street and highway
0.003 0.997 0.000
X47.3 Sports and athletics area
0.003 0.997 0.000
X47.2 School, other institution and public administrative area
0.003 0.997 0.000
X47.1 Residential institution
0.003 0.997 0.000
V98-V99 Other and unspecified transport accidents
0.003 0.997 0.000
C25.9 Pancreas, unspecified
0.003 0.997 0.000
C77.2 Intra-abdominal lymph nodes
0.000 0.997 0.003

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.